Results 61 to 70 of about 35,087 (150)

2019-NCoV: What every neurologist should know?

Annals of Indian Academy of Neurology, 2020
The 2019 novel Corona Virus pandemic beginning from Wuhan, China primarily affects the respiratory tract but its has impacted clinical practice across a range of specialities including neurology. We review the bearing of the 2019 NCoV infection on neurological practice.
Nitika Mahajan, Monika Singla, Balveen Singh, Venkatesh Sajja, Parth Bansal, Birinder Paul, Parveen Goel, Rahul Midha, Rajinder Bansal, Gagandeep Singh   +9 more
openaire   +4 more sources

Características clínicas, de laboratorio y radiológicas de pacientes pediátricos hospitalizados con COVID-19: serie de casos

Revista Peruana de Medicina Experimental y Salud Pública, 2020
De toda la población infectada por el SARS-CoV-2, la población pediátrica representa del 1 al 5%, siendo un reto caracterizarla clínicamente. Presentamos cinco casos de pacientes pediátricos con diagnóstico de COVID-19; el rango de edad fue de 1 a 14 ...
Héctor Nuñez-Paucar, Jorge L. Candela-Herrera, Franklin Aranda-Paniora, Cynthia L. Huby-Muñoz, Liz E. De Coll-Vela, Raúl R. Bernal-Mancilla, Mariela K. Zamudio-Aquise, Sandra C. Schult-Montoya   +7 more
doaj   +1 more source

SARS‐CoV‐2 Chronic Intervillositis: Variations of Maternal Antiviral Response

American Journal of Reproductive Immunology, Volume 95, Issue 2, February 2026.
ABSTRACT Problem Placental compromise is a determining factor in the outcome of pregnancies complicated by maternal SARS‐CoV‐2 infection. Chronic histiocytic intervillositis (CHI) is the initial response to SARS‐CoV‐2 infection, but the underlying mechanisms are poorly understood.
Daria Kozlova, Ori Mayer, Noam Shomron, Yosef Azan, Rani Shlayem, Yevgeni Yegorov, Nir Rainy, Avi Natan, Ana Foigelman Tobar   +8 more
wiley   +1 more source

Strengthening Respiratory Virus Surveillance in Sub‐Saharan Africa: Integrated Epidemiological and Genomic Monitoring in Côte d'Ivoire

Influenza and Other Respiratory Viruses, Volume 20, Issue 2, February 2026.
ABSTRACT Background Following WHO recommendations issued in 2019 and 2022, the National Influenza Center (NIC) of Côte d'Ivoire initiated the integration of Respiratory Syncytial Virus (RSV) and SARS‐CoV‐2 surveillance into its existing sentinel influenza surveillance to strengthen the monitoring of respiratory viruses.
Hervé A. Kadjo, Daouda Coulibaly, Yakoura Karidja Ouattara, Sylla Aboubacar, Diané Maxime, Nguessan Konan, Kouakou Luc‐Venance, Kouassi Helene, Mboua Jean Marc, Kouakou Bertin, Adagba Marius, Edgard Adjogoua, Ekra Daniel, Meite Syndou   +13 more
wiley   +1 more source

Medical Journals and the 2019-nCoV Outbreak

New England Journal of Medicine, 2020
Medical Journals and the Coronavirus The editors announce expedited handling for submitted manuscripts describing the 2019-nCoV outbreak and make broad recommendations for speed, transparency, and ...
Rubin, Eric J., Baden, Lindsey R., Morrissey, Stephen, Campion, Edward W.   +3 more
openaire   +2 more sources

The neutrophil‐to‐lymphocyte ratio as a marker of immunosenescence and COVID‐19 outcomes in the elderly: A narrative review

Physiological Reports, Volume 14, Issue 3, February 2026.
Abstract Older adults are highly vulnerable to severe COVID‐19. Unlike our previous work on broad immunosenescence, this review focuses on peripheral hematological markers as practical indicators of risk. To examine lymphopenia, neutrophilia, and the neutrophil‐to‐lymphocyte ratio (NLR) as clinically accessible markers of immune aging and COVID‐19 ...
Maha Gasmi, Kimia Torabinasab, Ruth Williams‐Hooker, Santo Marsigliante, Antonella Muscella   +4 more
wiley   +1 more source

COVID-2019: update on epidemiology, disease spread and management

Monaldi Archives for Chest Disease, 2020
With each passing day, more cases of Coronavirus disease (COVID-2019) are being detected and unfortunately the fear of novel corona virus 2019 (2019-nCoV) becoming a pandemic disease has come true.
Kamal Kant Sahu, Ajay Kumar Mishra, Amos Lal   +2 more
doaj   +1 more source

Short‐Term Change in IgG Antibody Elicited by Omicron BA.5 Infection and Inhaled Ad5‐nCoV Vaccine Among Healthcare Workers

Immunity, Inflammation and Disease, Volume 14, Issue 1, January 2026.
In this study, we recruited a cohort of healthcare workers who were infected with Omicron BA.5 or received inhaled adenovirus vector vaccine to investigate the short‐term profile of antireceptor‐binding‐domain IgG antibody elicited by the virus or vaccine.
Zhaohui Luo, Ting Zeng, Shi Zhao, Jing Liang, Shengzhi Sun, Yongkang Ni, Chunyan Yan, Liang Yin, Lan Wang, Kai Wang, Zihao Guo   +10 more
wiley   +1 more source

2019 novel coronavirus (2019-nCoV) outbreak: A new challenge

Journal of Global Antimicrobial Resistance, 2020
Objectives: Following the public-health emergency of international concern (PHEIC) declared by the World Health Organization (WHO) on 30 January 2020 and the recent outbreak caused by 2019 novel coronavirus (2019-nCoV) [officially renamed severe acute ...
Tommaso Lupia, Silvia Scabini, Simone Mornese Pinna, Giovanni Di Perri, Francesco Giuseppe De Rosa, Silvia Corcione   +5 more
doaj   +1 more source

Structural Adaptability of IgA and IgM Supports Broad SARS‐CoV‐2 Variant Neutralization

Journal of Medical Virology, Volume 98, Issue 1, January 2026.
ABSTRACT Neutralizing emerging SARS‐CoV‐2 variants requires antibodies effective not only against epitope mutations but also under variable antigenic presentations. We assessed the neutralization capacity of the same anti‐RBD monoclonal antibody (8A5) expressed as IgG, IgA, or IgM against 18 variants, identifying three neutralization classes: variants ...
Yalcin Pisil, Hisatoshi Shida, Sandra Morales Ruiz, Kyunghak Cho, Metehan Gungor, Zafer Yazici, Tomoyuki Miura   +6 more
wiley   +1 more source